Christopher Tickner
About Christopher Tickner
Christopher Tickner serves as the HSE Group Process Safety and Engineering Compliance Manager at Dechra Pharmaceuticals PLC, where he has worked since 2020. He possesses extensive experience in process safety, having held various roles in prominent pharmaceutical companies and holding qualifications in occupational health and safety.
Work at Dechra Pharmaceuticals
Christopher Tickner has been serving as the HSE Group - Process Safety and Engineering Compliance Manager at Dechra Pharmaceuticals PLC since 2020. In this role, he focuses on ensuring compliance with safety regulations and enhancing operational safety protocols. He has led HAZOP and risk assessment studies, which have contributed to improved safety measures within the organization. Additionally, he conducts SHE tours and audits to promote continuous improvement in safety and compliance standards.
Education and Expertise
Christopher Tickner holds a PhD from the University of Nottingham, which he completed from 2001 to 2004. He also earned a First Class degree in Chemistry (MChem Hons) from Newcastle University between 1997 and 2001. His educational background includes various certifications in occupational health and safety, such as the NEBOSH National General Certificate and NVQ Level 5 Diplomas from City and Guilds. His expertise includes reaction calorimetry, crucial for assessing thermal hazards in chemical processes, and DSEAR/ATEX area classification.
Background
Christopher Tickner has a diverse professional background in process safety and engineering compliance. He began his career as a CASE Placement at GSK in 2003 and has since held various positions in notable companies. His tenure at AstraZeneca included roles as a Senior Process Safety Scientist and Senior SHE Specialist, spanning over eight years. He also worked at Bristol-Myers Squibb as a Global Process Safety Specialist and Hazard Assessment Lead from 2017 to 2020.
Achievements
Throughout his career, Christopher Tickner has developed and implemented SHE improvement plans that focus on operational hazard identification and mitigation. His contributions include leading HAZOP and risk assessment studies at Dechra Pharmaceuticals, which have enhanced safety protocols. His extensive experience and expertise in safety compliance and hazard assessment have positioned him as a key figure in promoting safety standards within the organizations he has worked for.